Cover Image
市場調查報告書

體外毒性檢驗的全球市場 ∼2022年:產品與服務,毒性端點、檢驗 (ADME,經皮毒性,遺傳毒性,內臟器官毒性),技術,手法,各產業

In Vitro Toxicology Testing Market by Products (Assays) & Services, Toxicity Endpoints & Tests (ADME, Skin, Genotoxicity, Organ Toxicity), Technology (Cell-based, HTS), Method (Cellular Assays, Ex-Vivo), Industry - Forecast to 2022

出版商 MarketsandMarkets 商品編碼 298990
出版日期 內容資訊 英文 255 Pages
訂單完成後即時交付
價格
Back to Top
體外毒性檢驗的全球市場 ∼2022年:產品與服務,毒性端點、檢驗 (ADME,經皮毒性,遺傳毒性,內臟器官毒性),技術,手法,各產業 In Vitro Toxicology Testing Market by Products (Assays) & Services, Toxicity Endpoints & Tests (ADME, Skin, Genotoxicity, Organ Toxicity), Technology (Cell-based, HTS), Method (Cellular Assays, Ex-Vivo), Industry - Forecast to 2022
出版日期: 2017年09月26日 內容資訊: 英文 255 Pages
簡介

全球體外毒性檢驗市場,預計2017年達63億4000萬美元,2022年達87億4000萬美元,以6.6%的年複合成長率 (CAGR) 成長。該市場的成長,主要由是對動物檢驗的反對,新的、有前途的技術,初期階段查出毒性的R&D增加,及促進體外檢驗手法的利用的不完全的資料庫所推動。

本報告提供全球體外毒性檢驗市場相關調查,市場概要,產業趨勢,各產品/服務、檢驗種類、技術、產業、手法、地區的市場分析,競爭情形,並提供主要企業簡介等資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

第5章 市場考察

  • 簡介
  • 供應鏈分析
  • 法規委員會的活動
    • 主要的利害關係者
    • 主要的影響要素
  • 產業趨勢
    • 在製藥/生物醫藥品產業的研究開發 (R&D) 投資的增加
    • 新且有前途的技術進步:市場相關人員的主要關心領域

第6章 市場概要

  • 簡介
  • 市場動態
    • 推動因素
      • 對動物實驗的反對
      • 體外檢驗有前途的新技術
      • 在初期階段的毒性探測用研究開發 (R&D) 投資的增加
    • 阻礙因素
      • 想起對於安全性、功效性的替代性提供手段,規定當局的抗拒感
      • 「透過體外 (In Vitro) 檢驗的體內 (In Vivo) 情形的診斷」的複雜檢驗手法:確立失敗
      • 缺乏為了研究複雜端點的體外模式
    • 市場機會
      • Tox21 (Toxicology in the 21st century) 計劃
      • 藥物研發數量的增加,與體外毒性檢驗市場創新、更新
      • 隨著毒素資料庫的擴充,體外檢驗手法的利用增加
    • 課題
      • 熟練專家的不足

第7章 體外毒性檢驗市場:各產品與服務

  • 簡介
  • 審定分析 (化驗)
    • 細菌毒性分析
    • 酵素毒性分析
    • 細胞株ELISA和西方墨點法
    • 受體結合化驗
    • 組織培養化驗
    • 其他
  • 服務
  • 試劑、儀器

第8章 體外毒性檢驗市場:各毒性端點、檢查

  • 簡介
    • ADME (吸收、分佈、代謝、排泄)
    • 皮膚刺激性、腐蝕性、敏感性
    • 遺傳毒性檢驗
    • 細胞毒性檢驗
    • 眼毒性
    • 內臟器官毒性
    • 光毒性檢驗
    • 經皮毒性
    • 致癌性
    • 神經毒性
    • 其他毒性端點、檢驗

第9章 體外毒性檢驗市場:各技術

  • 簡介
  • 細胞培養技術
  • 高通量技術
  • 細胞影像技術
  • 毒理基因體學 (毒性基因學)

第10章 體外毒性檢驗市場:各產業

  • 簡介
  • 製藥、生物醫藥品產業
  • 化妝品、家用品產業
  • 食品產業
  • 化學產業

第11章 體外毒性檢驗市場:各手法

  • 簡介
  • 細胞分析
  • 生物化學分析
  • 體外 (EX VIVO) 模式

第12章 體外毒性檢驗市場:各地區

  • 簡介
  • 歐洲 (德國,英國,法國,義大利,西班牙等)
  • 北美 (美國,加拿大)
  • 亞太地區 (日本,中國,印度等)
  • 其他的國家 (RoW)

第13章 競爭環境

  • 概要
  • 市場排行榜分析

第14章 企業簡介

  • SGS S.A.
  • COVANCE, INC. (LABORATORY CORPORATION OF AMERICA HOLDINGS的一部門)
  • BIO-RAD LABORATORIES, INC.
  • QIAGEN N.V.
  • GE HEALTHCARE
  • EUROFINS SCIENTIFIC SE
  • MERCK KGAA
  • THERMO FISHER SCIENTIFIC, INC
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
  • CATALENT, INC.
  • CYPROTEX PLC (EVOTEC AG的子公司)
  • PROMEGA CORPORATION
  • GENTRONIX LIMITED
  • ASCENDANCE BIOTECHNOLOGY, INC.
  • MB RESEARCH LABORATORIES

第15章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: BT 2373

"The global in vitro toxicology testing market is projected to grow at a CAGR of 6.6%."

The in vitro toxicology testing market is expected to reach USD 8.74 billion by 2022 from an estimated USD 6.34 billion in 2017, at a CAGR of 6.6%. The key factors driving the growth of this market include opposition to animal testing, growing demand for in vitro technology in the European market, new and promising technologies, and increasing R&D expenditure to detect toxicity at an early stage. On the other hand, failure to establish intricacies of in vivo conditions through in vitro, lack of in vitro models to study complex endpoints, and a dearth of skilled professionals are the major factors restraining the growth of this market.

"The services segment is expected to grow at the highest CAGR during the forecast period."

On the basis of product and services, the in vitro toxicology testing market is segmented into assays, services, and reagents and labware. The services segment is expected to witness the highest growth during the forecast period. The growth of this segment can be attributed to the growing preference towards contract research in vitro toxicology testing services owing to the cost benefits offered by CROs.

"Toxicogenomics to grow at the highest rate in the global in vitro toxicology testing market by technology"

Based on technology, the in vitro toxicology testing market is segmented into cell culture, high-throughput, cellular imaging, and toxicogenomics technologies. The toxicogenomics segment is expected to account for the highest CAGR in the global in the vitro toxicology testing market. Toxicogenomics is preferred to elucidate the changes in gene expression in response to toxic exposure and facilitates to identify toxicity pathways.

"The Ex vivo models segment is expected to grow at the highest CAGR during the forecast period."

Based on method, the in vitro toxicology testing market is segmented into cellular assays, biochemical assays, and ex vivo models. Ex vivo models segment is expected to grow at the highest CAGR during the forecast period owing to the growing adoption of these methods in the cosmetics industry as it is an effective alternative to animal testing for the toxicity testing of cosmetics and household products.

"China to witness the highest growth during the forecast period (2017-2022)"

The US is expected to hold the largest share of the global in vitro toxicology testing market in 2017, while China is expected to witness the highest growth during 2017 to 2022. Growing R&D investments in the biopharmaceutical sector, coupled with the rising number of CROs in this country contribute to the growth of this market in China. Additionally, rising international pressure on Chinese cosmetics industry to ban animal testing is expected to further drive this market.

Break of primary participants was as mentioned below:

  • By Company Type - Tier 1-25%, Tier 2-35% and Tier 3-40%
  • By Designation - C-level-22%, Director Level-33%, Others-45%
  • By Region - North America-30%, Europe-40%, Asia Pacific-15%, RoW-15%

The major players in the global in vitro toxicology testing market include Cyprotex (An Evotec AG subsidiary, Germany), Covance (A Laboratory Corporations of America Holding's subsidiary, US), Eurofins Scientific SE (Luxembourg), GE Healthcare (US), Thermo Fisher Scientific (US), SGS SA (Switzerland), Promega Corporation (US), Merck KGaA (Germany), Charles River Laboratories, Inc. (US), and Lonza Group Ltd. (Switzerland), among others.

Research Coverage:

The report analyzes the in vitro toxicology testing market and aims at estimating the market size and future growth potential of this market based on various aspects such as product and service; toxicity endpoint and tests; technology; method; industry; and region. The report also includes an in-depth regulatory analysis for various regions across the globe and competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report:

The report will help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in-turn would help them, garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product portfolios offered by key players in the global in vitro toxicology testing market. The report analyzes the global in vitro toxicology testing market by product and service; toxicity endpoint and tests; technology; method; industry; and region.
  • Product and Service Innovation: Detailed insights on upcoming trends and new product and service launches in the global in vitro toxicology testing market
  • Market Development: Comprehensive information about the lucrative emerging markets by product and service; toxicity endpoint and tests; technology; method; and industry.
  • Market Diversification: Exhaustive information about new products, growing geographies, recent developments, and investments in the global in vitro toxicology testing market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, products in pipeline of leading players in the global market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS COVERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
  • 2.2. MARKET SHARE ESTIMATION
    • 2.2.1. SECONDARY DATA
      • 2.2.1.1. Key data from secondary sources
    • 2.2.2. PRIMARY DATA
      • 2.2.2.1. Key data from primary sources
      • 2.2.2.2. Key industry insights
  • 2.3. MARKET SIZE ESTIMATION
  • 2.4. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.5. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. GLOBAL IN VITRO TOXICOLOGY TESTING MARKET OVERVIEW
  • 4.2. EUROPE IN VITRO TOXICOLOGY TESTING MARKET: BY TECHNOLOGY & COUNTRY
  • 4.3. IN VITRO TOXICOLOGY TESTING MARKET: BY COUNTRY/REGION
  • 4.4. IN VITRO TOXICOLOGY TESTING MARKET: GEOGRAPHIC MIX
  • 4.5. IN VITRO TOXICOLOGY TESTING MARKET: DEVELOPING VS. DEVELOPED MARKETS (USD BILLION)

5. INDUSTRY INSIGHTS

  • 5.1. INTRODUCTION
  • 5.2. SUPPLY CHAIN ANALYSIS
  • 5.3. REGULATORY COMMITTEE ACTIVITIES
    • 5.3.1. MAJOR STAKEHOLDERS
    • 5.3.2. KEY INFLUENCERS
  • 5.4. INDUSTRY TRENDS
    • 5.4.1. INCREASING R&D SPENDING IN THE PHARMACEUTICAL AND BIOTECHNOLOGY SECTOR
    • 5.4.2. NEW AND PROMISING TECHNOLOGICAL ADVANCEMENTS A KEY AREA OF FOCUS FOR MARKET PLAYERS

6. MARKET OVERVIEW

  • 6.1. INTRODUCTION
  • 6.2. MARKET DYNAMICS
    • 6.2.1. DRIVERS
      • 6.2.1.1. Opposition to animal testing
      • 6.2.1.2. New and promising in vitro technologies
      • 6.2.1.3. Increasing R&D expenditure to detect toxicity at an early stage
    • 6.2.2. RESTRAINTS
      • 6.2.2.1. Reluctance of regulatory authorities to consider alternative methods for proving safety and efficacy
      • 6.2.2.2. Failure to establish intricacies of in vivo conditions through in vitro
      • 6.2.2.3. Lack of in vitro models to study complex endpoints
    • 6.2.3. OPPORTUNITIES
      • 6.2.3.1. Toxicology in the 21st century (Tox21) program
      • 6.2.3.2. Increasing drug discovery and innovation & modernization in the in vitro toxicity testing market
      • 6.2.3.3. Increasing toxicology databases will facilitate the use of in vitro test methods
    • 6.2.4. CHALLENGES
      • 6.2.4.1. Dearth of skilled professionals

7. IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE

  • 7.1. INTRODUCTION
  • 7.2. ASSAYS
    • 7.2.1. BACTERIAL TOXICITY ASSAYS
    • 7.2.2. ENZYME TOXICITY ASSAYS
    • 7.2.3. CELL-BASED ELISA AND WESTERN BLOTS
    • 7.2.4. RECEPTOR-BINDING ASSAYS
    • 7.2.5. TISSUE CULTURE ASSAYS
    • 7.2.6. OTHER ASSAYS
  • 7.3. SERVICES
  • 7.4. REAGENTS & LABWARE

8. IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINTS AND TESTS

  • 8.1. INTRODUCTION
    • 8.1.1. ADME (ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION)
    • 8.1.2. SKIN IRRITATION, CORROSION, AND SENSITIZATION
    • 8.1.3. GENOTOXICITY TESTING
    • 8.1.4. CYTOTOXICITY TESTING
    • 8.1.5. OCULAR TOXICITY
    • 8.1.6. ORGAN TOXICITY
    • 8.1.7. PHOTOTOXICITY TESTING
    • 8.1.8. DERMAL TOXICITY
    • 8.1.9. CARCINOGENICITY
    • 8.1.10. NEUROTOXICITY
    • 8.1.11. OTHER TOXICITY ENDPOINTS & TESTS

9. IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY

  • 9.1. INTRODUCTION
  • 9.2. CELL CULTURE TECHNOLOGIES
  • 9.3. HIGH-THROUGHPUT TECHNOLOGIES
  • 9.4. CELLULAR IMAGING TECHNOLOGIES
  • 9.5. TOXICOGENOMICS

10. IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY

  • 10.1. INTRODUCTION
  • 10.2. PHARMACEUTICAL AND BIOPHARMACEUTICAL INDUSTRY
  • 10.3. COSMETICS AND HOUSEHOLD PRODUCTS INDUSTRY
  • 10.4. FOOD INDUSTRY
  • 10.5. CHEMICAL INDUSTRY

11. IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD

  • 11.1. INTRODUCTION
  • 11.2. CELLULAR ASSAYS
  • 11.3. BIOCHEMICAL ASSAYS
  • 11.4. EX VIVO MODELS

12. IN VITRO TOXICOLOGY TESTING MARKET, BY REGION

  • 12.1. INTRODUCTION
  • 12.2. EUROPE
    • 12.2.1. GERMANY
    • 12.2.2. UK
    • 12.2.3. FRANCE
    • 12.2.4. ITALY
    • 12.2.5. SPAIN
    • 12.2.6. REST OF EUROPE (ROE)
  • 12.3. NORTH AMERICA
    • 12.3.1. US
    • 12.3.2. CANADA
  • 12.4. ASIA PACIFIC
    • 12.4.1. JAPAN
    • 12.4.2. CHINA
    • 12.4.3. INDIA
    • 12.4.4. REST OF ASIA PACIFIC (ROAPAC)
  • 12.5. REST OF THE WORLD (ROW)

13. COMPETITIVE LANDSCAPE

  • 13.1. OVERVIEW
  • 13.2. MARKET RANKING ANALYSIS

14. COMPANY PROFILES (Overview, Products and Services, Financials, Strategy & Development)*

  • 14.1. SGS S.A.
  • 14.2. COVANCE, INC. (A PART OF LABORATORY CORPORATION OF AMERICA HOLDINGS)
  • 14.3. BIO-RAD LABORATORIES, INC.
  • 14.4. QIAGEN N.V.
  • 14.5. GE HEALTHCARE
  • 14.6. EUROFINS SCIENTIFIC SE
  • 14.7. MERCK KGAA
  • 14.8. THERMO FISHER SCIENTIFIC, INC
  • 14.9. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
  • 14.10. CATALENT, INC.
  • 14.11. CYPROTEX PLC (A SUBSIDIARY OF EVOTEC AG)
  • 14.12. PROMEGA CORPORATION
  • 14.13. GENTRONIX LIMITED
  • 14.14. ASCENDANCE BIOTECHNOLOGY, INC.
  • 14.15. MB RESEARCH LABORATORIES

*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.

15. APPENDIX

  • 15.1. INSIGHTS OF INDUSTRY EXPERTS
  • 15.2. DISCUSSION GUIDE
  • 15.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 15.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 15.5. RELATED REPORTS
  • 15.6. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2015-2022 (USD MILLION)
  • TABLE 2: IN VITRO TOXICOLOGY TESTING MARKET FOR ASSAYS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 3: IN VITRO TOXICOLOGY TESTING MARKET FOR ASSAYS, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 4: IN VITRO TOXICOLOGY TESTING MARKET FOR BACTERIAL TOXICITY ASSAYS, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 5: IN VITRO TOXICITY TESTING MARKET FOR ENZYME TOXICITY ASSAYS, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 6: IN VITRO TOXICOLOGY TESTING MARKET FOR CELL-BASED ELISA AND WESTERN BLOTS, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 7: IN VITRO TOXICOLOGY TESTING MARKET FOR RECEPTOR-BINDING ASSAYS, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 8: IN VITRO TOXICOLOGY TESTING MARKET FOR TISSUE CULTURE ASSAYS, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 9: IN VITRO TOXICOLOGY TESTING MARKET FOR OTHER ASSAYS, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 10: IN VITRO TOXICOLOGY TESTING MARKET FOR SERVICES, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 11: IN VITRO TOXICOLOGY TESTING MARKET FOR REAGENTS & LABWARE, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 12: IN VITRO TOXICITY TESTING MARKET, BY TOXICITY ENDPOINT AND TEST, 2015-2022 (USD MILLION)
  • TABLE 13: IN VITRO TOXICITY TESTING MARKET FOR ADME, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 14: IN VITRO TOXICITY TESTING MARKET FOR SKIN IRRITATION, CORROSION, AND SENSITIZATION, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 15: IN VITRO TOXICITY TESTING MARKET FOR GENOTOXICITY TESTING, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 16: IN VITRO TOXICITY TESTING MARKET FOR CYTOTOXICITY TESTING, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 17: IN VITRO TOXICITY TESTING MARKET FOR OCULAR TOXICITY, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 18: IN VITRO TOXICITY TESTING MARKET FOR ORGAN TOXICITY, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 19: IN VITRO TOXICITY TESTING MARKET FOR PHOTOTOXICITY TESTING, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 20: IN VITRO TOXICITY TESTING MARKET FOR DERMAL TOXICITY, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 21: IN VITRO TOXICITY TESTING MARKET FOR CARCINOGENICITY, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 22: IN VITRO TOXICITY TESTING MARKET FOR NEUROTOXICITY, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 23: IN VITRO TOXICITY TESTING MARKET FOR OTHER TOXICITY ENDPOINT & TEST, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 24: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 25: IN VITRO TOXICOLOGY TESTING MARKET FOR CELL CULTURE TECHNOLOGIES, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 26: IN VITRO TOXICOLOGY TESTING MARKET FOR HIGH-THROUGHPUT TECHNOLOGIES, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 27: IN VITRO TOXICOLOGY TESTING MARKET FOR CELLULAR IMAGING TECHNOLOGIES, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 28: IN VITRO TOXICOLOGY TESTING MARKET FOR TOXICOGENOMICS, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 29: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2015-2022 (USD MILLION)
  • TABLE 30: IN VITRO TOXICOLOGY TESTING MARKET FOR PHARMACEUTICALS AND BIOPHARMACEUTICALS INDUSTRY, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 31: IN VITRO TOXICOLOGY TESTING MARKET FOR COSMETICS & HOUSEHOLD PRODUCTS INDUSTRY, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 32: IN VITRO TOXICOLOGY TESTING MARKET FOR THE FOOD INDUSTRY, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 33: IN VITRO TOXICOLOGY TESTING MARKET SIZE FOR THE CHEMICAL INDUSTRY, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 34: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2015-2022 (USD MILLION)
  • TABLE 35: IN VITRO TOXICOLOGY TESTING MARKET FOR CELLULAR ASSAYS, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 36: IN VITRO TOXICOLOGY TESTING MARKET FOR BIOCHEMICAL ASSAYS, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 37: IN VITRO TOXICOLOGY TESTING MARKET FOR EX VIVO ASSAYS, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 38: IN VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 39: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 40: EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 41: EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2015-2022(USD MILLION)
  • TABLE 42: EUROPE: IN VITRO TOXICOLOGY TESTING MARKET FOR ASSAYS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 43: EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2015-2022 (USD MILLION)
  • TABLE 44: EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 45: EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2015-2022 (USD MILLION)
  • TABLE 46: EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2015-2022 (USD MILLION)
  • TABLE 47: GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2015-2022(USD MILLION)
  • TABLE 48: GERMANY: IN VITRO TOXICOLOGY TESTING MARKET FOR ASSAYS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 49: GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2015-2022 (USD MILLION)
  • TABLE 50: GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 51: GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2015-2022 (USD MILLION)
  • TABLE 52: GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2015-2022 (USD MILLION)
  • TABLE 53: UK: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2015-2022(USD MILLION)
  • TABLE 54: UK: IN VITRO TOXICOLOGY TESTING MARKET FOR ASSAYS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 55: UK: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2015-2022 (USD MILLION)
  • TABLE 56: UK: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 57: UK: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2015-2022 (USD MILLION)
  • TABLE 58: UK: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2015-2022 (USD MILLION)
  • TABLE 59: FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2015-2022 (USD MILLION)
  • TABLE 60: FRANCE: IN VITRO TOXICOLOGY TESTING MARKET FOR ASSAYS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 61: FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TESTS, 2015-2022 (USD MILLION)
  • TABLE 62: FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 63: FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2015-2022 (USD MILLION)
  • TABLE 64: FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2015-2022 (USD MILLION)
  • TABLE 65: ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2015-2022 (USD MILLION)
  • TABLE 66: ITALY: IN VITRO TOXICOLOGY TESTING MARKET FOR ASSAYS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 67: ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2015-2022 (USD MILLION)
  • TABLE 68: ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 69: ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2015-2022 (USD MILLION)
  • TABLE 70: ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2015-2022 (USD MILLION)
  • TABLE 71: SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2015-2022(USD MILLION)
  • TABLE 72: SPAIN: IN VITRO TOXICOLOGY TESTING MARKET FOR ASSAYS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 73: SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TESTS, 2015-2022 (USD MILLION)
  • TABLE 74: SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 75: SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2015-2022 (USD MILLION)
  • TABLE 76: SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2015-2022 (USD MILLION)
  • TABLE 77: ROE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2015-2022(USD MILLION)
  • TABLE 78: ROE: IN VITRO TOXICOLOGY TESTING MARKET FOR ASSAYS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 79: ROE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2015-2022 (USD MILLION)
  • TABLE 80: ROE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 81: ROE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2015-2022 (USD MILLION)
  • TABLE 82: ROE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2015-2022 (USD MILLION)
  • TABLE 83: NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 84: NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2015-2022(USD MILLION)
  • TABLE 85: NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR ASSAYS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 86: NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2015-2022 (USD MILLION)
  • TABLE 87: NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 88: NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2015-2022 (USD MILLION)
  • TABLE 89: NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2015-2022 (USD MILLION)
  • TABLE 90: US: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2015-2022(USD MILLION)
  • TABLE 91: US: IN VITRO TOXICOLOGY TESTING MARKET FOR ASSAYS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 92: US: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2015-2022 (USD MILLION)
  • TABLE 93: US: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 94: US: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2015-2022 (USD MILLION)
  • TABLE 95: US: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2015-2022 (USD MILLION)
  • TABLE 96: CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2015-2022(USD MILLION)
  • TABLE 97: CANADA: IN VITRO TOXICOLOGY TESTING MARKET FOR ASSAYS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 98: CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2015-2022 (USD MILLION)
  • TABLE 99: CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 100: CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2015-2022 (USD MILLION)
  • TABLE 101: CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2015-2022 (USD MILLION)
  • TABLE 102: APAC: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY/REGION, 2015-2022 (USD MILLION)
  • TABLE 103: APAC: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2015-2022(USD MILLION)
  • TABLE 104: APAC: IN VITRO TOXICOLOGY TESTING MARKET FOR ASSAYS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 105: APAC: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2015-2022 (USD MILLION)
  • TABLE 106: APAC: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 107: APAC: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2015-2022 (USD MILLION)
  • TABLE 108: APAC: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2015-2022 (USD MILLION)
  • TABLE 109: JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2015-2022(USD MILLION)
  • TABLE 110: JAPAN: IN VITRO TOXICOLOGY TESTING MARKET FOR ASSAYS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 111: JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TESTS, 2015-2022 (USD MILLION)
  • TABLE 112: JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 113: JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2015-2022 (USD MILLION)
  • TABLE 114: JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2015-2022 (USD MILLION)
  • TABLE 115: CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2015-2022(USD MILLION)
  • TABLE 116: CHINA: IN VITRO TOXICOLOGY TESTING MARKET FOR ASSAYS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 117: CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2015-2022 (USD MILLION)
  • TABLE 118: CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 119: CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2015-2022 (USD MILLION)
  • TABLE 120: CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2015-2022 (USD MILLION)
  • TABLE 121: INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2015-2022(USD MILLION)
  • TABLE 122: INDIA: IN VITRO TOXICOLOGY TESTING MARKET FOR ASSAYS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 123: INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2015-2022 (USD MILLION)
  • TABLE 124: INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 125: INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2015-2022 (USD MILLION)
  • TABLE 126: INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2015-2022 (USD MILLION)
  • TABLE 127: ROAPAC: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2015-2022(USD MILLION)
  • TABLE 128: ROAPAC: IN VITRO TOXICOLOGY TESTING MARKET FOR ASSAYS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 129: ROAPAC: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TESTS, 2015-2022 (USD MILLION)
  • TABLE 130: ROAPAC: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 131: ROAPAC: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2015-2022 (USD MILLION)
  • TABLE 132: ROAPAC: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2015-2022 (USD MILLION)
  • TABLE 133: ROW: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2015-2022(USD MILLION)
  • TABLE 134: ROW: IN VITRO TOXICOLOGY TESTING MARKET FOR ASSAYS, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 135: ROW: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2015-2022 (USD MILLION)
  • TABLE 136: ROW: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2015-2022 (USD MILLION)
  • TABLE 137: ROW: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2015-2022 (USD MILLION)
  • TABLE 138: ROW: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2015-2022 (USD MILLION)
  • TABLE 139: RANK OF COMPANIES IN THE IN VITRO TOXICOLOGY TESTING MARKET, 2016

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2017 VS. 2022 (USD BILLION)
  • FIGURE 7: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017 VS. 2022 (USD MILLION)
  • FIGURE 8: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017 VS. 2022 (USD BILLION)
  • FIGURE 9: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017 VS. 2022 (USD BILLION)
  • FIGURE 10: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017 VS. 2022 (USD BILLION)
  • FIGURE 11: GEOGRAPHICAL SNAPSHOT OF THE IN VITRO TOXICOLOGY TESTING MARKET, 2017
  • FIGURE 12: OPPOSITION TO ANIMAL TESTING AND INCREASE IN R&D SPENDING TO DRIVE MARKET GROWTH
  • FIGURE 13: TOXICOGENOMICS TECHNOLOGIES IS EXPECTED TO COMMAND THE LARGEST MARKET SHARE IN 2017
  • FIGURE 14: CHINA TO REGISTER HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 15: EUROPE HOLDS THE HIGHEST MARKET SHARE DURING THE FORECAST PERIOD
  • FIGURE 16: DEVELOPING MARKETS TO GROW AT THE HIGHEST CAGRS FROM 2017 TO 2022
  • FIGURE 17: SUPPLY CHAIN ANALYSIS: IN VITRO TOXICOLOGY TESTING MARKET (AS OF 2016)
  • FIGURE 18: IN VITRO TOXICOLOGY TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 19: GLOBAL IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT (2017)
  • FIGURE 20: EUROPE: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT, 2017 (USD MILLION)
  • FIGURE 21: ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT (2017)
  • FIGURE 22: SGS S.A.: COMPANY SNAPSHOT (2016)
  • FIGURE 23: LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT (2016)
  • FIGURE 24: BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 25: QIAGEN N.V.: COMPANY SNAPSHOT (2016)
  • FIGURE 26: GE HEALTHCARE: COMPANY SNAPSHOT (2016)
  • FIGURE 27: EUROFINS SCIENTIFIC SE: COMPANY SNAPSHOT (2016)
  • FIGURE 28: MERCK KGAA: COMPANY SNAPSHOT (2016)
  • FIGURE 29: THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 30: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 31: CATALENT, INC.: COMPANY SNAPSHOT (2016)
  • FIGURE 32: EVOTEC AG: COMPANY SNAPSHOT (2016)
Back to Top